Anteotech Ltd (ADO) - Net Assets

Latest as of December 2025: AU$2.03 Million AUD ≈ $1.44 Million USD

Based on the latest financial reports, Anteotech Ltd (ADO) has net assets worth AU$2.03 Million AUD (≈ $1.44 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$4.85 Million ≈ $3.43 Million USD) and total liabilities (AU$2.82 Million ≈ $1.99 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how strategically is Anteotech Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$2.03 Million
% of Total Assets 41.87%
Annual Growth Rate -3.45%
5-Year Change -85.08%
10-Year Change -77.32%
Growth Volatility 148.02

Anteotech Ltd - Net Assets Trend (1999–2025)

This chart illustrates how Anteotech Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see ADO market cap overview.

Annual Net Assets for Anteotech Ltd (1999–2025)

The table below shows the annual net assets of Anteotech Ltd from 1999 to 2025. Also explore ADO year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Year Net Assets Change
2025-06-30 AU$3.15 Million
≈ $2.23 Million		 -40.63%
2024-06-30 AU$5.31 Million
≈ $3.75 Million		 +123.26%
2023-06-30 AU$2.38 Million
≈ $1.68 Million		 -80.76%
2022-06-30 AU$12.36 Million
≈ $8.74 Million		 -41.48%
2021-06-30 AU$21.11 Million
≈ $14.94 Million		 +557.91%
2020-06-30 AU$3.21 Million
≈ $2.27 Million		 -24.22%
2019-06-30 AU$4.24 Million
≈ $3.00 Million		 +5.82%
2018-06-30 AU$4.00 Million
≈ $2.83 Million		 -43.66%
2017-06-30 AU$7.10 Million
≈ $5.03 Million		 -48.85%
2016-06-30 AU$13.89 Million
≈ $9.83 Million		 +161.36%
2015-06-30 AU$5.31 Million
≈ $3.76 Million		 -25.18%
2014-06-30 AU$7.10 Million
≈ $5.02 Million		 +155.83%
2013-06-30 AU$2.78 Million
≈ $1.96 Million		 -41.84%
2012-06-30 AU$4.77 Million
≈ $3.38 Million		 -30.74%
2011-06-30 AU$6.89 Million
≈ $4.88 Million		 +394.22%
2010-06-30 AU$1.39 Million
≈ $986.60K		 +35.03%
2009-06-30 AU$1.03 Million
≈ $730.63K		 -65.70%
2008-06-30 AU$3.01 Million
≈ $2.13 Million		 +94.22%
2007-06-30 AU$1.55 Million
≈ $1.10 Million		 -2.63%
2006-06-30 AU$1.59 Million
≈ $1.13 Million		 +202.21%
2005-06-30 AU$526.71K
≈ $372.68K		 -75.01%
2004-06-30 AU$2.11 Million
≈ $1.49 Million		 -39.00%
2003-06-30 AU$3.46 Million
≈ $2.45 Million		 -45.77%
2002-06-30 AU$6.37 Million
≈ $4.51 Million		 -37.52%
2001-06-30 AU$10.20 Million
≈ $7.22 Million		 +39.44%
2000-06-30 AU$7.31 Million
≈ $5.18 Million		 -6.87%
1999-06-30 AU$7.85 Million
≈ $5.56 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Anteotech Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 10663710400.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Common Stock AU$103.78 Million 3294.29%
Other Comprehensive Income AU$6.03 Million 191.39%
Total Equity AU$3.15 Million 100.00%

Anteotech Ltd Competitors by Market Cap

The table below lists competitors of Anteotech Ltd ranked by their market capitalization.

Company Market Cap
Ortoma AB Series B
ST:ORT-B
 $35.77 Million
Bedmutha Industries Limited
NSE:BEDMUTHA
 $35.79 Million
QT Imaging Holdings, Inc. Common Stock
NASDAQ:QTI
 $35.80 Million
Mount Logan Capital Inc. Common Stock
NASDAQ:MLCI
 $35.80 Million
Monnari Trade S.A.
WAR:MON
 $35.75 Million
TJ media Co. Ltd
KQ:032540
 $35.74 Million
Bio-Works Technologies AB
ST:BIOWKS
 $35.73 Million
NUREXONE BIOLOGIC INC.
F:J90
 $35.72 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Anteotech Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 5,305,923 to 3,150,205, a change of -2,155,718 (-40.6%).
  • Net loss of 6,759,135 reduced equity.
  • Share repurchases of 3,960,050 reduced equity.
  • New share issuances of 3,960,050 increased equity.
  • Other comprehensive income increased equity by 643,367.
  • Other factors increased equity by 3,960,050.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income AU$-6.76 Million -214.56%
Share Repurchases AU$3.96 Million -125.71%
Share Issuances AU$3.96 Million +125.71%
Other Comprehensive Income AU$643.37K +20.42%
Other Changes AU$3.96 Million +125.71%
Total Change AU$- -40.63%

Book Value vs Market Value Analysis

This analysis compares Anteotech Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 14.10x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 0.02x to 14.10x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1999-06-30 AU$0.74 AU$0.02 x
2000-06-30 AU$0.88 AU$0.02 x
2001-06-30 AU$0.81 AU$0.02 x
2002-06-30 AU$0.53 AU$0.02 x
2003-06-30 AU$0.26 AU$0.02 x
2004-06-30 AU$0.15 AU$0.02 x
2005-06-30 AU$0.04 AU$0.02 x
2006-06-30 AU$0.02 AU$0.02 x
2007-06-30 AU$0.01 AU$0.02 x
2008-06-30 AU$0.02 AU$0.02 x
2009-06-30 AU$0.00 AU$0.02 x
2010-06-30 AU$0.00 AU$0.02 x
2011-06-30 AU$0.01 AU$0.02 x
2012-06-30 AU$0.01 AU$0.02 x
2013-06-30 AU$0.00 AU$0.02 x
2014-06-30 AU$0.01 AU$0.02 x
2015-06-30 AU$0.01 AU$0.02 x
2016-06-30 AU$0.01 AU$0.02 x
2017-06-30 AU$0.01 AU$0.02 x
2018-06-30 AU$0.00 AU$0.02 x
2019-06-30 AU$0.00 AU$0.02 x
2020-06-30 AU$0.00 AU$0.02 x
2021-06-30 AU$0.01 AU$0.02 x
2022-06-30 AU$0.01 AU$0.02 x
2023-06-30 AU$0.00 AU$0.02 x
2024-06-30 AU$0.00 AU$0.02 x
2025-06-30 AU$0.00 AU$0.02 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Anteotech Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -214.56%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -697.62%
  • • Asset Turnover: 0.15x
  • • Equity Multiplier: 2.05x
  • Recent ROE (-214.56%) is below the historical average (-124.06%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1999 0.03% 0.00% 0.00x 1.00x AU$-783.39K
2000 -7.46% 0.00% 0.00x 1.08x AU$-1.28 Million
2001 -13.74% -2501.79% 0.00x 1.13x AU$-2.42 Million
2002 -143.80% -709.84% 0.16x 1.25x AU$-9.80 Million
2003 -85.25% -73.83% 0.79x 1.46x AU$-3.29 Million
2004 -134.21% -66.10% 1.25x 1.63x AU$-3.04 Million
2005 -299.98% -1669.31% 0.13x 1.39x AU$-1.63 Million
2006 -392.33% -771.36% 0.42x 1.20x AU$-6.40 Million
2007 -100.85% -1714.93% 0.05x 1.26x AU$-1.72 Million
2008 -58.53% -2172.25% 0.02x 1.15x AU$-2.06 Million
2009 -188.75% -861.20% 0.17x 1.29x AU$-2.05 Million
2010 -161.72% -848.54% 0.15x 1.24x AU$-2.39 Million
2011 -32.24% -18757.39% 0.00x 1.06x AU$-2.91 Million
2012 -49.87% -1622.36% 0.03x 1.09x AU$-2.86 Million
2013 -78.50% -992.41% 0.07x 1.18x AU$-2.46 Million
2014 -35.09% -804.50% 0.04x 1.08x AU$-3.20 Million
2015 -79.44% -900.42% 0.08x 1.13x AU$-4.75 Million
2016 -42.89% -822.11% 0.01x 3.78x AU$-7.34 Million
2017 -148.19% -425.85% 0.05x 6.45x AU$-11.24 Million
2018 -90.85% -1537.90% 0.05x 1.12x AU$-4.04 Million
2019 -77.85% -2194.44% 0.03x 1.13x AU$-3.72 Million
2020 -97.44% -1044.41% 0.08x 1.22x AU$-3.45 Million
2021 -29.44% -692.15% 0.04x 1.12x AU$-8.33 Million
2022 -86.74% -1408.51% 0.05x 1.24x AU$-11.95 Million
2023 -532.44% -3459.99% 0.07x 2.26x AU$-12.89 Million
2024 -167.38% -1928.99% 0.05x 1.77x AU$-9.41 Million
2025 -214.56% -697.62% 0.15x 2.05x AU$-7.07 Million

Industry Comparison

This section compares Anteotech Ltd's net assets metrics with peer companies in the Specialty Chemicals industry.

Industry Context

  • Industry: Specialty Chemicals
  • Average net assets among peers: $459,366,445
  • Average return on equity (ROE) among peers: -65.69%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Anteotech Ltd (ADO) AU$2.03 Million 0.03% 1.39x $35.76 Million
5E Advanced Materials Inc (5EA) $63.19 Million -49.94% 0.12x $73.44 Million
Alexium International Group Ltd (AJX) $39.22 Million -96.78% 3.20x $15.49 Million
Altech Batteries Ltd (ATC) $7.43 Million -10.16% 0.04x $1.89 Million
Carbonxt Group Ltd (CG1) $4.47 Million -160.27% 1.39x $24.22 Million
CALIX Ltd (CXL) $16.81 Million -44.56% 0.50x $38.98 Million
DGL Group Ltd (DGL) $339.05 Million 9.12% 0.66x $56.51 Million
Dyno Nobel Ltd (DNL) $3.71 Billion 12.50% 0.89x $4.87 Billion
DOTZ Nano Ltd (DTZ) $-43.33 Million 0.00% 0.00x $13.73 Million
Foresta Group Holdings Ltd (FGH) $762.12K -251.08% 0.60x $18.20 Million

About Anteotech Ltd

AU:ADO Australia Specialty Chemicals
Market Cap
$35.76 Million
AU$50.54 Million AUD
Market Cap Rank
#23259 Global
#873 in Australia
Share Price
AU$0.02
Change (1 day)
-5.56%
52-Week Range
AU$0.01 - AU$0.04
All Time High
AU$0.44
Categories
Companies in Australia Specialty Chemicals
About

AnteoTech Limited develops, manufactures, commercializes, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, and North America. The company's products include AnteoBind, a metal-ion complex-based activation technology that offers an alternative to conventionally used chemistries for the life sciences industry; AnteoBind NXT solution… Read more